Document:

EXHIBIT 4.1

                                 FORM OF WARRANT

         THESE  SECURITIES HAVE NOT BEEN REGISTERED  UNDER THE SECURITIES ACT OF
         1933, AS AMENDED,  OR THE  SECURITIES  LAWS OF ANY STATE AND MAY NOT BE
         SOLD OR OFFERED  FOR SALE IN THE ABSENCE OF AN  EFFECTIVE  REGISTRATION
         STATEMENT FOR THE SECURITIES OR AN OPINION OF COUNSEL OR OTHER EVIDENCE
         ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

                          CELL POWER TECHNOLOGIES, INC.

                          COMMON STOCK PURCHASE WARRANT

                  1. Issuance; Certain Definitions. In consideration of good and
valuable  consideration,   the  receipt  and  sufficiency  of  which  is  hereby
acknowledged  by CELL  POWER  TECHNOLOGIES,  INC.,  a Florida  corporation  (the
"Company"), ____________________________ or registered assigns (the "Holder") is
hereby  granted the right to purchase at any time until 5:00 P.M., New York City
time,  on the  Expiration  Date (as  defined  below),_________________  Thousand
__________  (____________)  fully paid and nonassessable shares of the Company's
Common  Stock,  no par per share (the "Common  Stock"),  at an initial  exercise
price per share (the  "Exercise  Price") of $1.25 per share,  subject to further
adjustment  as set forth  herein.  This Warrant is being issued  pursuant to the
terms of that  certain  Subscription  Agreement,  dated as of  _____,  2004 (the
"Agreement"),  to which the  Company  and Holder  (or  Holder's  predecessor  in
interest) are parties.

                  2. Exercise of Warrants.

                           2.1      General.

                           (a) This Warrant is  exercisable  in whole or in part
at any  time and  from  time to time.  Such  exercise  shall be  effectuated  by
submitting  to the Company  (either by  delivery to the Company or by  facsimile
transmission  as  provided in Section 8 hereof) a  completed  and duly  executed
Notice  of  Exercise  (substantially  in  the  form  attached  to  this  Warrant
Certificate) as provided in this paragraph.  The date such Notice of Exercise is
faxed to the Company shall be the "Exercise  Date,"  provided that the Holder of
this Warrant  tenders this Warrant  Certificate  to the Company  within five (5)
business days thereafter. The Notice of Exercise shall be executed by the Holder
of this  Warrant and shall  indicate  the number of shares then being  purchased
pursuant to such exercise. Upon surrender of this Warrant Certificate,  together
with  appropriate  payment of the Exercise  Price for the shares of Common Stock
purchased, the Holder shall be entitled to receive a certificate or certificates
for the shares of Common Stock so purchased.

<PAGE>

                           (b) The Exercise  Price per share of Common Stock for
the shares  then being  exercised  shall be payable in cash or by  certified  or
official bank check.

                           (c) The  Holder  shall be deemed to be the  holder of
the shares  issuable to it in accordance with the provisions of this Section 2.1
on the Exercise Date.

                           2.2  Certain  Definitions.  As used  herein,  each of
the  following  terms  has the  meaning  set forth  below,  unless  the  context
otherwise requires:

                           (a) "Closing  Price"  means the closing  price during
regular  trading  hours of the Common Stock (in U.S.  Dollars) on the  Principal
Trading Market, as reported by the Reporting Service.

                           (b)  "Expiration  Date" means the earlier of _______,
2009 or the Early Expiration Date (as defined below).

                           (c)  "Principal  Trading  Market"  means the Over the
Counter Bulletin Board Market.

                           (d) "Reporting Service" means Bloomberg LP or if that
service is not then  reporting  the relevant  information  regarding  the Common
Stock, a comparable  reporting  service of national  reputation  selected by the
Holder and reasonably acceptable to the Company.

                           (e) "Target Price" means $2.75 per share,  subject to
further  adjustment in the same manner as  adjustments to the Exercise Price are
made herein.

                           (f)  "Trading  Day"  means any day  during  which the
Principal Trading Market shall be open for business.

                           2.3   Early  Expiration Date. So long as an effective
registration  statement exists with respect to the resale of the shares issuable
on exercise of this  Warrant,  if the Closing Price for the Common Stock is more
than the Target Price for each of ten (10)  consecutive  Trading Days (the tenth
of such  consecutive  Trading Days, the "Target Trading Day"),  then the Company
will have the right to give the Holder a written  notice  (an "Early  Expiration
Date  Notice")  within ten (10) Trading  Days after the Target  Trading Day. The
Early  Expiration  Date Notice shall state that the  Expiration  Date shall be a
date specified in such notice (the "Early  Expiration  Date"),  which date shall
not be earlier than thirty (30) days after the Target Trading Day.

<PAGE>

                  3.  Reservation  of Shares.  The Company hereby agrees that at
all times during the term of this  Warrant  there shall be reserved for issuance
upon exercise of this Warrant such number of shares of its Common Stock as shall
be required for issuance upon exercise of this Warrant (the "Warrant Shares").

                  4. Mutilation or Loss of Warrant.  Upon receipt by the Company
of evidence satisfactory to it of the loss, theft,  destruction or mutilation of
this  Warrant,  and (in the  case of  loss,  theft or  destruction)  receipt  of
reasonably  satisfactory  indemnification,  and (in the case of mutilation) upon
surrender and cancellation of this Warrant, the Company will execute and deliver
a new  Warrant of like tenor and date and any such lost,  stolen,  destroyed  or
mutilated Warrant shall thereupon become void.

                  5.  Rights of the  Holder.  The Holder  shall  not,  by virtue
hereof, be entitled to any rights of a stockholder in the Company, either at law
or equity,  and the rights of the Holder are limited to those  expressed in this
Warrant and are not  enforceable  against  the Company  except to the extent set
forth herein.

                  6. Protection Against Dilution and Other Adjustments.

                           6.1   Adjustment  Mechanism.  If an adjustment of the
Exercise  Price is  required  pursuant  to this  Section 6, the Holder  shall be
entitled to purchase such number of shares of Common Stock as will cause (i) (x)
the  total  number of shares of Common  Stock  Holder is  entitled  to  purchase
pursuant to this  Warrant  following  such  adjustment ,  multiplied  by (y) the
adjusted  Exercise  Price per share,  to equal the result of (ii) (x) the dollar
amount of the total  number of shares  of Common  Stock  Holder is  entitled  to
purchase  before  adjustment,  multiplied by (y) the total Exercise Price before
adjustment.(1)

                           6.2   Capital Adjustments. In case of any stock split
or reverse stock split,  stock dividend,  reclassification  of the Common Stock,
recapitalization,  merger  or  consolidation  (where  the  Company  is  not  the
surviving entity),  the provisions of this Section 6 shall be applied as if such
capital  adjustment  event had  occurred  immediately  prior to the date of this
Warrant and the original  Exercise Price had been fairly  allocated to the stock
resulting from such capital adjustment;  and in other respects the provisions of
this Section shall be applied in a fair,  equitable and reasonable  manner so as
to give effect,  as nearly as may be, to the purposes  hereof. A rights offering
to  stockholders  shall be deemed a stock  dividend to the extent of the bargain
purchase element of the rights.

----------
(1)   Example:  Assume  100,000  shares remain under Warrant at original  stated
      Exercise Price of $1.50.  Total exercise price (clause (y) in text) is (i)
      100,000 x (ii)  $1.50,  or  $150,000.  Company  effects  2:1 stock  split.
      Exercise Price is adjusted  $0.75.  Number of shares covered by Warrant is
      adjusted to 200,000,  because  (applying clause (x) in text) (i) 200,000 x
      (ii) $0.75 = $150,000.

<PAGE>

                  7. Transfer to Comply with the  Securities  Act;  Registration
Rights.

                           7.1  Transfer.  This Warrant has not been  registered
under the Securities Act of 1933, as amended, (the "Act") and has been issued to
the Holder for investment and not with a view to the  distribution of either the
Warrant or the  Warrant  Shares.  Neither  this  Warrant  nor any of the Warrant
Shares or any other  security  issued or issuable  upon exercise of this Warrant
may be sold, transferred, pledged or hypothecated in the absence of an effective
registration  statement under the Act relating to such security or an opinion of
counsel  satisfactory to the Company that registration is not required under the
Act. Each certificate for the Warrant, the Warrant Shares and any other security
issued or issuable  upon  exercise of this Warrant shall contain a legend on the
face  thereof,  in form and substance  satisfactory  to counsel for the Company,
setting forth the restrictions on transfer contained in this Section.

                           7.2 Registration Rights. (a) Reference is made to the
Registration  Rights Agreement  entered into by the Company and the Holder as of
_________,  2004.  The  Company's  obligations  under  the  Registration  Rights
Agreement and the other terms and conditions thereof with respect to the Warrant
Shares,  including,  but not necessarily limited to, the Company's commitment to
file a  registration  statement  including  the  Warrant  Shares,  to  have  the
registration of the Warrant Shares completed and effective, and to maintain such
registration, are incorporated herein by reference.

                           (b) In addition to the  registration  rights referred
to in the preceding provisions of Section 7.2(a), effective after the expiration
of the  effectiveness  of the  Registration  Statement  as  contemplated  by the
Registration  Rights  Agreement,  the Holder shall have piggy-back  registration
rights  with  respect  to the  Warrant  Shares  then held by the  Holder or then
subject to issuance upon exercise of this Warrant (collectively,  the "Remaining
Warrant  Shares"),  subject to the conditions  set forth below.  If, at any time
after the  Registration  Statement  has  ceased  to be  effective,  the  Company
participates  (whether  voluntarily  or by  reason of an  obligation  to a third
party) in the  registration  of any shares of the Company's  stock (other than a
registration  on Form S-8 or on Form S-4), the Company shall give written notice
thereof to the Holder and the Holder  shall have the right,  exercisable  within
ten (10) business days after receipt of such notice,  to demand inclusion of all
or a portion  of the  Holder's  Remaining  Warrant  Shares in such  registration
statement.  If the Holder exercises such election,  the Remaining Warrant Shares
so  designated  shall be included in the  registration  statement  at no cost or
expense to the Holder (other than any costs or commissions  which would be borne
by the  Holder  under  the  terms of the  Registration  Rights  Agreement).  The
Holder's rights under this Section 7 shall expire at such time as the Holder can
sell all of the Remaining  Warrant Shares under Rule 144 without volume or other
restrictions or limit.

<PAGE>

                  8.  Notices.  Any notice or other  communication  required  or
permitted hereunder shall be in writing and shall be delivered personally,  sent
by facsimile  transmission  or sent by  certified,  registered  or express mail,
return  receipt  requested,  postage  pre-paid.  Any such notice shall be deemed
given  when so  delivered  personally,  or sent by  confirmed  and  acknowledged
facsimile transmission,  or, if so mailed, two days after the date of deposit in
the United States mails, as follows:

                           (i)      if to the Company, to:

                                    CELL POWER TECHNOLOGIES, INC.
                                    1428 36TH Street
                                    Brooklyn, New York 11218
                                    Attn: President
                                    Telephone No.: (718) 436-7931
                                    Telecopier No.: (718)

                           with a copy to:

                                    Aboudi & Brounstein
                                    Attn: David Aboudi, Esq.
                                    Rechov Gavish 3, POB 2432
                                    Kfar Saba Industrial Zone 44641 Israel
                                    Telephone No.: (011-972-9) 764-4833
                                    Telecopier No.: (011-972-9) 764-4834

                           (ii)     if to the Holder, to:

                                    Attn:
                                    Telephone No.:  (   )    -
                                    Telecopier No.: (   )    -

                                    with a copy to:

Any party may,  by notice  given in  accordance  with this  Section to the other
parties, designate another address or person for receipt of notices hereunder.

<PAGE>

                  9. Supplements and Amendments;  Whole Agreement.  This Warrant
may be amended or  supplemented  only by an instrument in writing  signed by the
parties  hereto.  This Warrant  contains the full  understanding  of the parties
hereto with  respect to the subject  matter  hereof and thereof and there are no
representations,  warranties,  agreements or understandings other than expressly
contained herein and therein.

                  10.  Governing  Law.  This  Warrant  shall be  deemed  to be a
contract made under the laws of the State of New York for contracts to be wholly
performed  in such state and without  giving  effect to the  principles  thereof
regarding the conflict of laws. Each of the parties consents to the jurisdiction
of the federal  courts whose  districts  encompass  New York County or the state
courts of the State of New York  sitting in New York County in  connection  with
any dispute arising under this Warrant and hereby waives,  to the maximum extent
permitted by law, any  objection,  including  any  objection  based on forum non
conveniens, to the bringing of any such proceeding in such jurisdictions. To the
extent  determined by such court, the Company shall reimburse the Holder for any
reasonable legal fees and disbursements  incurred by the Buyer in enforcement of
or protection of any of its rights under any of the Transaction Agreements.

                  11. JURY TRIAL WAIVER. The Company and the Holder hereby waive
a trial by jury in any action,  proceeding or counterclaim  brought by either of
the Parties  hereto against the other in respect of any matter arising out or in
connection with this Warrant.

                  12.  Counterparts.  This Warrant may be executed in any number
of counterparts and each of such  counterparts  shall for all purposes be deemed
to be an original,  and all such counterparts shall together  constitute but one
and the same instrument.

                   [Balance of page intentionally left blank]

<PAGE>

                  13. Descriptive Headings.  Descriptive headings of the several
Sections of this Warrant are inserted for convenience only and shall not control
or affect the meaning or construction of any of the provisions hereof.

         IN WITNESS WHEREOF, the parties hereto have executed this Warrant as of
the day of _______________, 2004.

                                                 CELL POWER TECHNOLOGIES, INC.

                                                 By: /s/ Jacob Herskovits

                                                 Jacob Herskovits
                                                 (Print Name)

                                                 President
                                                 (Title)EXHIBIT 10.1

                             SUBSCRIPTION AGREEMENT

                                                                 May _____, 2004
Cell Power Technologies, Inc.
1428 36th Street
Brooklyn NY 11258

Ladies and Gentlemen:

1.)      The undersigned  hereby tenders this  subscription  and applies for the
         purchase of the number of the units  (hereinafter,  a "Unit") set forth
         on the signature  page of this  agreement,  with each Unit comprised of
         32,000  shares of the Company's  common  stock,  no par value per share
         (the  "Shares") and a five-year  warrant (the  "Warrants")  to purchase
         32,000  additional  share of common stock at a per share exercise price
         of $1.25,  at a per Unit cost of $24,000.  The minimum  purchase is one
         Unit  ($24,000),  provided,  however,  that  a  lesser  amount  may  be
         purchased  in  the  discretion  of  the  Company.  Together  with  this
         Subscription Agreement, the undersigned is delivering to the Company, a
         check payable to "American  Stock transfer & Trust  Company,  AS ESCROW
         AGENT  FOR CELL  POWER  TECHNOLOGIES,  INC." in the full  amount of the
         purchase price for the Units which the  undersigned is subscribing  for
         pursuant  hereto,  or  funds  by wire  transfer  as  instructed  by the
         Company.

         The Shares and Warrants to be purchased by the  undersigned are part of
         a private  placement of securities  (the "Private  Placement") of up to
         160 Units.  The Units will be offered by the Company on a "best efforts
         all  or  none"  basis  as to  the  Minimum  Offering  of  $504,000  and
         thereafter  on a "best  efforts"  basis up to the  Maximum  Offering of
         $3,000,000. There are a minimum number of 21 Units that must be sold in
         order for the Private Placement to become  effective.  If all the Units
         are sold,  the  Company  will  receive an  aggregate  of three  million
         dollars ($3,000,000) less the expenses of the Private Placement,  which
         management  estimates will be approximately  Fifty thousand  ($50,000),
         which does not  include  commissions  and fees  payable to a  placement
         agent.

2.)      Representations  and  Warranties.  In order to induce  the  Company  to
         accept  this  subscription,   the  undersigned  hereby  represents  and
         warrants to, and covenants with, the Company as follows:

         (a)      The   undersigned   has  received  and  reviewed  the  Private
                  Placement Memorandum dated May 2004 (hereinafter, collectively
                  the  "Offering  Materials"),   and  except  for  the  Offering
                  Materials,  the  undersigned  has not  relied  upon any  other
                  materials or literature  relating to the offer and sale of the
                  Units;

         (b)      The  undersigned  has  had a  reasonable  opportunity  to  ask
                  questions of and receive  answers from the Company  concerning
                  the Company and the offering, and all such questions,  if any,
                  have  been   answered   to  the  full   satisfaction   of  the
                  undersigned;

         (c)      The  undersigned has such knowledge and expertise in financial
                  and  business  matters  that the  undersigned  is  capable  of
                  evaluating  the merits and risks  involved in an investment in
                  the Units.

         (d)      The information  provided by the investor in this Subscription
                  Agreement  being  delivered by the  undersigned to the Company
                  herewith  is  true,  complete  and  correct  in  all  material

                                       1
<PAGE>

                  respects, and the undersigned understands that the Company has
                  determined that the exemption from the registration provisions
                  of the Securities  Act of 1933, as amended (the "Act"),  which
                  is based upon non-public offerings, is applicable to the offer
                  and   sale  of  the   Units,   based,   in   part,   upon  the
                  representations,   warranties  and  agreements   made  by  the
                  undersigned herein;

         (e)      Except   as  set   forth  in  the   Offering   Materials,   no
                  representations   or   warranties   have   been  made  to  the
                  undersigned  by the  Company  or by any  agent,  employee,  or
                  affiliate   of  the  Company,   and  in  entering   into  this
                  transaction   the   undersigned   is  not  relying   upon  any
                  information,   other  than  that  contained  in  the  Offering
                  Materials and the results of independent  investigation by the
                  undersigned;

         (f)      The undersigned  understands  that: (A) Neither the Units, the
                  Shares nor the Warrants have been registered  under the Act or
                  the securities laws of any state, and are being offered by the
                  Company  based  upon  an  exemption  from  such   registration
                  requirements for non-public offerings pursuant to Regulation D
                  under the Act; (B) the Units, Shares and Warrants are and will
                  be  "restricted  securities,"  as said term is defined in Rule
                  144 of the Rules and  Regulations  promulgated  under the Act;
                  (C)  Neither  the  Units,  Shares or  Warrants  may be sold or
                  otherwise  transferred  unless they have been first registered
                  under the Act and all  applicable  state  securities  laws, or
                  unless  exemptions  from  such  registration   provisions  are
                  available  with respect to said resale or transfer;  (D) other
                  than as set forth in the  Offering  Materials,  the Company is
                  under no  obligation  to register  the Shares under the Act or
                  any state  securities  laws, or to take any action to make any
                  exemption from any such registration provisions available; (E)
                  the  certificates  for the  Shares  and  Warrants  will bear a
                  legend  to the  effect  that the  transfer  of the  securities
                  represented  thereby is subject to the provisions  hereof; and
                  (F)  stop  transfer  instructions  will  be  placed  with  the
                  Company's transfer agent, if any, for the Shares and Warrants;

         (g)      The  undersigned is acquiring the Units solely for the account
                  of the undersigned, for investment purposes only, and not with
                  a view towards their resale or distribution;

         (h)      The undersigned will not sell or otherwise transfer any of the
                  Units,   Shares  or  Warrants  unless  and  until:   (A)  said
                  securities  shall have first been registered under the Act and
                  all applicable  state  securities laws; or (B) the undersigned
                  shall have first delivered to the Company a written opinion of
                  counsel  (which  counsel and  opinion (in form and  substance)
                  shall  be  reasonably  satisfactory  to the  Company),  to the
                  effect that the  proposed  sale or transfer is exempt from the
                  registration  provisions of the Act and all  applicable  state
                  securities laws;

         (i)      The  undersigned  has full power and  authority to execute and
                  deliver  this  Subscription   Agreement  and  to  perform  its
                  obligations  hereunder,  and this Subscription  Agreement is a
                  legally  binding  obligation of the  undersigned in accordance
                  with its terms;

         (j)      The undersigned  meets the requirements of at least one of the
                  suitability  standards for an  "accredited  investor," as such
                  term is defined in  Regulation D of the Rules and  Regulations
                  promulgated   under   the  Act  and  as  set   forth  in  this
                  Subscription Agreement and as the undersigned has indicated in
                  the Accredited Investor Certification attached hereto;

         (k)      The  undersigned  has  carefully  reviewed  the  Risk  Factors
                  associated  with an  investment  in the Units  outlined in the
                  Offering Materials and understands that the securities offered

                                       2
<PAGE>

                  hereby are highly  speculative  and  involve a high  degree of
                  risk and should not be purchased  by anyone who cannot  afford
                  the loss of his entire investment; and

         (l)      The undersigned represents that it was not induced to purchase
                  the Units as a result of advertising or public solicitation by
                  the Company and that prompt  written  notice will be furnished
                  to the Company in respect of a change in its  principal  place
                  of business or principal residence, as appropriate.

                              JURISDICTIONAL NOTICE

Residents of All States:

                  THE SECURITIES  OFFERED HEREBY HAVE NOT BEEN REGISTERED  UNDER
         THE  SECURITIES  ACT OF 1933,  AS AMENDED,  OR THE  SECURITIES  LAWS OF
         CERTAIN STATES AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS
         FROM THE  REGISTRATION  REQUIREMENTS  OF SAID ACT AND  SUCH  LAWS.  THE
         SECURITIES ARE SUBJECT TO  RESTRICTIONS ON  TRANSFERABILITY  AND RESALE
         AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID ACT
         AND  SUCH  LAWS  PURSUANT  TO  REGISTRATION  OR  EXEMPTION   THEREFROM.
         INVESTORS  SHOULD  BE AWARE  THAT  THEY  WILL BE  REQUIRED  TO BEAR THE
         FINANCIAL  RISKS OF THIS  INVESTMENT FOR AN INDEFINITE  PERIOD OF TIME.
         THE SECURITIES  HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
         AND EXCHANGE COMMISSION,  ANY STATE SECURITIES  COMMISSION OR ANY OTHER
         REGULATORY AUTHORITY.  NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED
         UPON OR  ENDORSED  THE  MERITS  OR THIS  OFFERING  OR THE  ACCURACY  OR
         ADEQUACY OF THE OFFERING MATERIALS.  ANY REPRESENTATION TO THE CONTRARY
         IS UNLAWFUL.

3.)      The undersigned  understands that this subscription is not binding upon
         the Company  until the Company  accepts it, which  acceptance is at the
         sole  discretion of the Company and is to be evidenced by the Company's
         execution  of  this  Subscription   Agreement  where  indicated.   This
         Subscription  Agreement  shall be null and void if the Company does not
         accept it as aforesaid.

4.)      The  undersigned   understands  that  the  Company  may,  in  its  sole
         discretion,  reject  this  subscription  and,  in the  event  that  the
         offering to which the  Offering  Materials  relates is  oversubscribed,
         offer  partial Units or reduce this  subscription  in any amount and to
         any extent,  whether or not pro rata  reductions  are made of any other
         investor's subscription.

5.)      The  undersigned  agrees to indemnify  the Company and hold it harmless
         from and against any and all losses, damages,  liabilities,  costs, and
         expenses which it may sustain or incur in connection with the breach by
         the undersigned of any  representation,  warranty,  or covenant made by
         the undersigned.

6.)      Neither  this  Subscription  Agreement  nor  any of the  rights  of the
         undersigned   hereunder   may  be   transferred   or  assigned  by  the
         undersigned.

7.)      This  Subscription  Agreement:  (i) may only be  modified  by a written
         instrument executed by the undersigned and the Company; (ii) sets forth
         the entire agreement of the undersigned and the Company with respect to
         the subject matter  hereof;  (iii) shall be governed by the laws of the
         State  of New  York  applicable  to  contracts  made  and to be  wholly
         performed  therein;  and (iv)  shall  inure to the  benefit  of, and be

                                       3
<PAGE>

         binding  upon the  Company  and the  undersigned  and their  respective
         heirs, legal representatives, successors, and assignees.

8.)      Unless the context  otherwise  requires,  all personal pronouns used in
         this  Subscription  Agreement,  whether in the  masculine,  feminine or
         neuter gender, shall include all other genders.

9.)      All notices or other  communications  hereunder shall be in writing and
         shall be  deemed to have been duly  given if  delivered  personally  or
         mailed by certified  or  registered  mail,  return  receipt  requested,
         postage prepaid, as follows: if to the undersigned,  to the address set
         forth on the  signature  page  hereof;  and if to the  Company,  to the
         address  provided  above or to such other address as the Company or the
         undersigned shall have designated to the other by like notice.

                                       4
<PAGE>

IN WITNESS  WHEREOF,  the undersigned has executed this  Subscription  Agreement
this ___ day of ___ _______________, 2004.

_________________  X   $24,000    =  ___________________________
No. of Units        (Unit Price)     Subscription Price

If the Investor is a PARTNERSHIP,
CORPORATION or TRUST:

--------------------------------------
Signature

--------------------------------------
Print Name of Subscriber Organization

--------------------------------------
Print Name and Title of Person Signing

--------------------------------------------------------------------------------
                (All Subscribers should please print information
                     below exactly as you wish it to appear
                         in the records of the Company)

<TABLE>
<CAPTION>
<S>                                                <C>
------------------------------------------------   ----------------------------------------------
Name and capacity in which subscription is         Taxpayer I.D. Number
made -- see below for particular requirements

Address:                                           Address for notices, if different:

------------------------------------------------   ----------------------------------------------
Number and Street                                  Number and Street

------------------------------------------------   ----------------------------------------------
City                   State      Zip Code         City                   State      Zip Code
</TABLE>

ACCEPTANCE OF SUBSCRIPTION

The foregoing  subscription is hereby accepted by Cell Power Technologies,  Inc.
this _____ day of __________ 2004, for _________ Units.

Cell Power Technologies, Inc.

By: /s/ Jacob Herskovits

Name: Jacob Herskovits

Title: President

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]